Characteristics | Overall population (N=121) | P value | |
---|---|---|---|
Cohort 1 ( N =35) | Cohort 2 ( N =86) | ||
Baseline characteristics | |||
Age (years) | 71.7±11.4 | 73.6±12.3 | 0.418 |
Male, N (%) | 25 (71.4) | 60 (69.8) | 0.856 |
Hypertension, N (%) | 32 (91.4) | 73 (84.9) | 0.259 |
Diabetes mellitus, N (%) | 20 (57.1) | 37 (43.0) | 0.158 |
Dyslipidemia, N (%) | 12 (34.3) | 32 (37.2) | 0.762 |
Prior MI, N (%) | 18 (51.4) | 42 (48.8) | 0.796 |
Prior stroke/TIA, N (%) | 9 (25.7) | 16 (18.6) | 0.381 |
Prior heart failure, N (%) | 17 (48.6) | 34 (39.5) | 0.361 |
Uremia, N (%) | 7 (20.0) | 17 (19.8) | 0.977 |
Echocardiographic characteristics | |||
LAD (mm) | 46.59±7.88 | 44.04±8.25 | 0.138 |
LVEF (%) | 49.69±14.36 | 51.67±16.34 | 0.552 |
AF characteristics | |||
Paroxysmal AF, N (%) | 24 (68.6) | 36 (41.9) | 0.008 |
CHA2DS2-VASc score | 4.5±1.9 | 4.1±1.7 | 0.187 |
HAS-BLED score | 3.5±1.1 | 3.2±1.1 | 0.182 |